ArticleJournal of medicinal chemistry2025

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.

Svit Ferjančič Benetik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.